You can buy or sell BMY and other stocks, options, ETFs, and crypto commission-free!
Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It includes chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. Read More The company was founded in August 1933 and is headquartered in New York, NY.
New York, New York
52 Week High
52 Week Low
Research And Development
Bristol-Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know
Bristol-Myers Squibb (BMY) closed the most recent trading day at $49.21, moving -0.78% from the previous trading session. This move lagged the S&P 500's daily loss of 0.29%. Meanwhile, the Dow lost 0.55%, and the Nasdaq, a tech-heavy index, added 0.07%. Coming into today, shares of the biopharmaceutical company had lost 3.43% in the past month. In that same time, the Medical sector gained 2.03%, while the S&P 500 gained 2.14%. BMY will be looking to display strength as it nears its next earnings release, ...
Celgene Presents An Attractive Short-Term Investment Opportunity In March 2019
The proposed cash and stock acquisition of Celgene (CELG) by Bristol-Myers Squibb (BMY) saw the former's share price jump up from $66.64 on January 2 to $80.43 on January 3. Bristol-Myers Squibb has offered a total consideration of around $74 billion for Celgene.
Available Apr 25, Pre-Market